Health Affairs' Rob Lott interviews Tiffany Lemon of Arizona State University on her recent paper exploring the concept of ...

With a Senate vote looming and reports of an impending White House proposal, this article discusses what has transpired in ...

The Antimicrobial Resistance Strategic Coalition is proof that when experts unite around shared goals, they can drive real change, even in the absence of formal government mandates.

We aim to provide transparency in how Elevance Health plans address variations in clinical practices to ensure safe, ...

Margolis Center for Health Policy to the pod to discuss her recent Forefront article focused on how ACO REACH enabled ACOs to ...

When the sole manufacturer withdrew a critical cancer drug from Medicare and Medicaid, patients were left without options.

The majority of promotional expenditures are invested in drug samples, one of the industry’s most important marketing tactics ...

In late August 2025, CMS released Performance Year (PY) 2024 data for the Medicare Shared Savings Program (MSSP). This marked ...

The Inflation Reduction Act (IRA) of 2022 mandates price negotiations for certain drugs under Medicare, shortening the exclusivity period historically used to recoup research and development ...

Taylor holds a bachelor’s degree from the University of Washington (UW) School of Engineering in technical communication and a master’s degree in clinical informatics and patient-centered technology ...

Audrey Ford, MS, is a Policy Research Associate on the Health Care Transformation team at Duke-Margolis and supports projects on the Medicare accountable care portfol ...

Geoffrey Crawford serves as Staff Vice President of Medical Policy (US) for The Elevance Health Companies, Inc.